Femasys Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference

ATLANTA, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that the Kathy Lee-Sepsick, founder, president & chief executive officer, will present at the Piper Sandler 34^th Annual Healthcare Conference being held November 29 through December 1, 2022 at the Lotte New York Palace Hotel in New York, NY.

Piper Sandler 34^th Annual Healthcare Conference

Date:	Thursday, December 1, 2022
Time:	8:10 – 8:30 AM ET
Location:	SoHo Track | Hubbard 1, 5thFloor
Webcast:	https://event.webcasts.com/starthere.jsp?ei=1584811&tp_key=99517b8362

The Femasys management team will also participate in one-on-one meetings during the event. Investors interested in meeting with Company management should contact their Piper Sandler representative.

A link to the replay of the webcast will be posted on the Events and Presentations section of the Femasys website at: https://ir.femasys.com/events-and-presentations/presentations/

About Femasys

Femasys Inc. is a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health. Its two lead product candidates are FemBloc^® permanent birth control and FemaSeed^® localized directional insemination for infertility. The Company’s product for fallopian tube assessment by ultrasound, FemVue^®, is currently marketed in the United States. Femasys is also advancing FemCath^™, an intrauterine catheter for selective evaluation of the fallopian tubes and FemCerv^®, an endocervical tissue sampler that is the first product of the technology platform for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting. To learn more, visit www.femasys.com or follow us on Twitter and LinkedIn.

Contacts:

Investors
Chuck Padala
LifeSci Advisors, LLC
+1-917-741-7792
chuck@lifesciadvisors.com

Femasys Inc.
Investor Contact:
IR@femasys.com

Media Contact:
Media@femasys.com